EC Number |
Inhibitors |
Structure |
---|
2.7.11.13 | more |
the enzyme is inhibited by its regulatory subunit masking the active site, autoregulation by a pseudosubstrate mechanism, overview |
|
2.7.11.13 | more |
synthesis of peptides behaving as pseudosubstrates, determination of inhibitory potential |
|
2.7.11.13 | more |
synthesis of peptides behaving as pseudosubstrates, determination of inhibitory potential, sequences of the different enzyme forms, required sequence properties, overview |
|
2.7.11.13 | more |
insensitive to caspase-3 |
|
2.7.11.13 | more |
insensitive to PKC inhibitors known to interfere either with the regulatory or the catalytic domain |
|
2.7.11.13 | more |
no inhibition of PKCalpha by roscovitine, and purvalanol |
|
2.7.11.13 | more |
PKC isozymes interacting proteins, overview |
|
2.7.11.13 | more |
F-actin, latrunculin B, and phalloidin do not modulate the initial steps of enzyme activation process in living nerve cells |
|
2.7.11.13 | more |
no inhibition of PKCdelta by bisindolylmaleimide I |
|
2.7.11.13 | more |
rapamycin and wortmannin inhibit PKC betaII turnover |
|